PyInvesting

Market research

IDXX IDEXX Laboratories Inc

NASDAQ USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
44B
P/E ratio
39.06
Analyst target
698.9231
Dividend yield
Not available
Beta
1.54

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

IDEXX Laboratories, Inc is currently in a long term uptrend where the price is trading 30.6% above its 200 day moving average.

From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 15.6.

IDEXX Laboratories, Inc's total revenue rose by 19.1% to $721M since the same quarter in the previous year.

Its net income has increased by 93.1% to $175M since the same quarter in the previous year.

Finally, its free cash flow grew by 86.7% to $204M since the same quarter in the previous year.

Based on the above factors, IDEXX Laboratories, Inc gets an overall score of 5/5.